ArticleNature. Mental health2026
Probing biomarkers and clinical utility of reward learning across species using the Probabilistic Reward Task: 20 years of findings.
Article in Nature. Mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nociceptin orphanin F/Q Pathways are dysregulated by stress and modulate reward responsiveness and motivated behavior across species.Molecular psychiatry · 2026Article
- Research agenda to advance anhedonia assessment, understanding and treatment: an ECNP-GALENOS expert meeting report.BMJ mental health · 2026Review
- Brain rhythms of depression: A predictive processing perspective.Trends in neurosciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Disrupted reward processing, including reward learning, is a prominent feature of various neuropsychiatric disorders. Such abnormalities are particularly consequential in major depressive disorder, in which anhedonia (reduced reactivity to pleasurable stimuli) predicts a host of negative outcomes, including poor response to treatments, worse disease course, impaired psychosocial functioning, and suicide. Despite substantial research in this area, there are no approved treatments for anhedonia; reasons for such modest progress include the use of vastly disparate approaches to assess anhedonic behaviors in laboratory animals and humans (leading to poor translation) and overreliance on clinical scales in humans, which generally fail to parse important subdomains of reward processing. To address these and other gaps, in 2005 we published the first report evaluating the Probabilistic Reward Task (PRT) in individuals with elevated depressive symptoms. Rooted in signal detection theory, this task allows objective assessment of reward learning, i.e., a subject's propensity to modulate behavior as a function of reward. Critically, functionally identical PRT versions have been developed for mice, rats, non-human primates, and humans, and data across species are analyzed using identical formulas and computational models. In this review, we summarize 20 years of PRT findings, organized according to several forms of validity, including
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.